{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:49:46Z","timestamp":1791143386832,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R41DA033710-01A1"],"award-info":[{"award-number":["1R41DA033710-01A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BRST Labs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00213-022-06171-z","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:02:21Z","timestamp":1656547341000},"page":"2853-2862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy"],"prefix":"10.1007","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-7750","authenticated-orcid":false,"given":"Jed E.","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique M.","family":"Behm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaia L.","family":"Botts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Botts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry N.","family":"Willette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"issue":"1","key":"6171_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-publhealth-040617-013849","volume":"39","author":"DB Abrams","year":"2018","unstructured":"Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS (2018) Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu Rev Public Health 39(1):193\u2013213. https:\/\/doi.org\/10.1146\/annurev-publhealth-040617-013849","journal-title":"Annu Rev Public Health"},{"issue":"12","key":"6171_CR2","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.3390\/ijerph15122902","volume":"15","author":"K Adriaens","year":"2018","unstructured":"Adriaens K, Gucht DV, Baeyens F (2018) IQOSTM vs. e-cigarette vs. tobacco cigarette: a direct comparison of short-term effects after overnight-abstinence. Int J Environ Res Public Health 15(12):2902. https:\/\/doi.org\/10.3390\/ijerph15122902","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"6171_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1037\/0893-164X.22.4.472","volume":"22","author":"N Amodei","year":"2008","unstructured":"Amodei N, Lamb RJ (2008) Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced? Psychol Addict Behav 22(4):472\u2013485. https:\/\/doi.org\/10.1037\/0893-164X.22.4.472","journal-title":"Psychol Addict Behav"},{"key":"6171_CR4","doi-asserted-by":"publisher","unstructured":"Benowitz NL, Hukkanen J, Jacob P (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield JE, London ED, Pogun S (eds) Nicotine psychopharmacology, vol 192. Springer Berlin, Heidelberg, pp 29\u201360. https:\/\/doi.org\/10.1007\/978-3-540-69248-5_2","DOI":"10.1007\/978-3-540-69248-5_2"},{"key":"6171_CR5","doi-asserted-by":"publisher","unstructured":"Bergeria CL, Heil SH, Davis DR, Streck JM, Sigmon SC, Bunn JY, Tidey JW, Arger CA, Reed DD, Gallagher T, Hughes JR, Gaalema DE, Stitzer ML, Higgins ST (2019) Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content. Drug Alcohol Depend 197:56\u201364. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.004. Epub 2019 Feb 13","DOI":"10.1016\/j.drugalcdep.2019.01.004"},{"issue":"7179","key":"6171_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/bmj.318.7179.285","volume":"318","author":"T Blondal","year":"1999","unstructured":"Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A (1999) Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ (Clin Res Ed) 318(7179):285\u2013288. https:\/\/doi.org\/10.1136\/bmj.318.7179.285","journal-title":"BMJ (Clin Res Ed)"},{"issue":"5","key":"6171_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.addbeh.2006.06.028","volume":"32","author":"JC Cappelleri","year":"2007","unstructured":"Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG (2007) Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav 32(5):912\u2013923. https:\/\/doi.org\/10.1016\/j.addbeh.2006.06.028","journal-title":"Addict Behav"},{"issue":"5","key":"6171_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/1462220031000158690","volume":"5","author":"J Choi","year":"2003","unstructured":"Choi J, Dresler C, Norton M, Strahs K (2003) Pharmacokinetics of a nicotine polacrilex lozenge. Nicotine Tob Res 5(5):635\u2013644. https:\/\/doi.org\/10.1080\/1462220031000158690","journal-title":"Nicotine Tob Res"},{"key":"6171_CR9","volume-title":"Design and analysis of bioavailability and bioequivalence studies","author":"S-C Chow","year":"2009","unstructured":"Chow S-C, Liu J (2009) Design and analysis of bioavailability and bioequivalence studies, 3rd edn. CRC Press","edition":"3"},{"issue":"1","key":"6171_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1472-6904-7-11","volume":"7","author":"B Dautzenberg","year":"2007","unstructured":"Dautzenberg B, Nides M, Kienzler J-L, Callens A (2007) Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell\u00ae). BMC Clin Pharmacol 7(1):11. https:\/\/doi.org\/10.1186\/1472-6904-7-11","journal-title":"BMC Clin Pharmacol"},{"key":"6171_CR11","doi-asserted-by":"publisher","unstructured":"de Wit H, Dudish, S, Ambre, J (1993) Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology 112:324\u2013330. https:\/\/doi.org\/10.1007\/BF02244928","DOI":"10.1007\/BF02244928"},{"issue":"1","key":"6171_CR12","doi-asserted-by":"publisher","first-page":"19980","DOI":"10.1038\/s41598-020-76610-4","volume":"10","author":"JK Ebajemito","year":"2020","unstructured":"Ebajemito JK, McEwan M, Gale N, Camacho OM, Hardie G, Proctor CJ (2020) A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes. Sci Rep 10(1):19980. https:\/\/doi.org\/10.1038\/s41598-020-76610-4","journal-title":"Sci Rep"},{"issue":"4","key":"6171_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/tc.2005.015487","volume":"15","author":"J-F Etter","year":"2006","unstructured":"Etter J-F (2006) Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 15(4):280\u2013285. https:\/\/doi.org\/10.1136\/tc.2005.015487","journal-title":"Tob Control"},{"issue":"2","key":"6171_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2125.1985.tb02637.x","volume":"19","author":"C Feyerabend","year":"1985","unstructured":"Feyerabend C, Ings R, Russel M (1985) Nicotine pharmacokinetics and its application to intake from smoking. Br J Clin Pharmacol 19(2):239\u2013247. https:\/\/doi.org\/10.1111\/j.1365-2125.1985.tb02637.x","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"6171_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMp1707409","volume":"377","author":"S Gottlieb","year":"2017","unstructured":"Gottlieb S, Zeller M (2017) A nicotine-focused framework for public health. N Engl J Med 377(12):1111\u20131114. https:\/\/doi.org\/10.1056\/NEJMp1707409","journal-title":"N Engl J Med"},{"issue":"4","key":"6171_CR16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1046\/j.1471-4159.1994.62041390.x","volume":"62","author":"SR Grady","year":"2008","unstructured":"Grady SR, Marks MJ, Collins AC (2008) Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes. J Neurochem 62(4):1390\u20131398. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.62041390.x","journal-title":"J Neurochem"},{"key":"6171_CR17","doi-asserted-by":"publisher","unstructured":"Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T (2018) Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 2019(1). https:\/\/doi.org\/10.1002\/14651858.CD000146.pub5","DOI":"10.1002\/14651858.CD000146.pub5"},{"key":"6171_CR18","doi-asserted-by":"publisher","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr\u00f6m KO (1991) The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire. Br J Addict 86(9):1119\u201327. https:\/\/doi.org\/10.1111\/j.1360-0443.1991.tb01879.x","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"6171_CR19","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3389\/fphar.2019.01328","volume":"10","author":"S Hua","year":"2019","unstructured":"Hua S (2019) Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front Pharmacol 10:1328. https:\/\/doi.org\/10.3389\/fphar.2019.01328","journal-title":"Front Pharmacol"},{"issue":"3","key":"6171_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","volume":"43","author":"JR Hughes","year":"1986","unstructured":"Hughes JR (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43(3):289. https:\/\/doi.org\/10.1001\/archpsyc.1986.01800030107013","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"6171_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/tc.7.1.92a","volume":"7","author":"J Hughes","year":"1998","unstructured":"Hughes J, Hatsukami DK (1998) Errors in using tobacco withdrawal scale. Tob Control 7(1):92\u201393. https:\/\/doi.org\/10.1136\/tc.7.1.92a","journal-title":"Tob Control"},{"issue":"5","key":"6171_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/add.14549","volume":"114","author":"SE Jackson","year":"2019","unstructured":"Jackson SE, McGowan JA, Ubhi HK, Proudfoot H, Shahab L, Brown J, West R (2019) Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation. Addiction 114(5):787\u2013797. https:\/\/doi.org\/10.1111\/add.14549","journal-title":"Addiction"},{"issue":"1","key":"6171_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/jn.00269.2013","volume":"111","author":"JL Koranda","year":"2014","unstructured":"Koranda JL, Cone JJ, McGehee DS, Roitman MF, Beeler JA, Zhuang X (2014) Nicotinic receptors regulate the dynamic range of dopamine release in vivo. J Neurophysiol 111(1):103\u2013111. https:\/\/doi.org\/10.1152\/jn.00269.2013","journal-title":"J Neurophysiol"},{"key":"6171_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.addbeh.2017.02.018","volume":"71","author":"M Kotlyar","year":"2017","unstructured":"Kotlyar M, Lindgren BR, Vuchetich JP, Le C, Mills AM, Amiot E, Hatsukami DK (2017) Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms. Addict Behav 71:18\u201324. https:\/\/doi.org\/10.1016\/j.addbeh.2017.02.018","journal-title":"Addict Behav"},{"key":"6171_CR25","unstructured":"McCarty JA (2015) Transmucosal drug delivery system (Patent No. US 8,992,974)"},{"issue":"12","key":"6171_CR26","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1080\/09652140120089508","volume":"96","author":"A McNeill","year":"2001","unstructured":"McNeill A, Foulds J, Bates C (2001) Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction (Abingdon, England) 96(12):1757\u20131768. https:\/\/doi.org\/10.1080\/09652140120089508","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"6171_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13690-021-00550-2","volume":"79","author":"AG Mersha","year":"2021","unstructured":"Mersha AG, Eftekhari P, Bovill M, Tollosa DN, Gould GS (2021) Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: a systematic review and meta-analysis. Arch Public Health 79(1):26. https:\/\/doi.org\/10.1186\/s13690-021-00550-2","journal-title":"Arch Public Health"},{"issue":"11","key":"6171_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s002280000223","volume":"56","author":"L Molander","year":"2001","unstructured":"Molander L, Lunell E (2001) Pharmacokinetic investigation of a nicotine sublingual tablet. Eur J Clin Pharmacol 56(11):813\u2013819. https:\/\/doi.org\/10.1007\/s002280000223","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"6171_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/ijerph18020576","volume":"18","author":"JC Morgan","year":"2021","unstructured":"Morgan JC, Cappella JN (2021) Harm perceptions and beliefs about potential modified risk tobacco products. Int J Environ Res Public Health 18(2):576. https:\/\/doi.org\/10.3390\/ijerph18020576","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"6171_CR30","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/ntr\/ntp104","volume":"11","author":"RP Murray","year":"2009","unstructured":"Murray RP, Connett JE, Zapawa LM (2009) Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study. Nicotine Tob Res 11(9):1076\u20131082. https:\/\/doi.org\/10.1093\/ntr\/ntp104","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"6171_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40262-020-00960-5","volume":"60","author":"PO Olsson Gisleskog","year":"2021","unstructured":"Olsson Gisleskog PO, Perez Ruixo JJ, Westin \u00c5, Hansson AC, Soons PA (2021) Nicotine population pharmacokinetics in healthy smokers after intravenous, oral, buccal and transdermal administration. Clin Pharmacokinet 60(4):541\u2013561. https:\/\/doi.org\/10.1007\/s40262-020-00960-5","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"6171_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","volume":"84","author":"MR Picciotto","year":"2008","unstructured":"Picciotto MR, Addy NA, Mineur YS, Brunzell DH (2008) It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84(4):329\u2013342. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.12.005","journal-title":"Prog Neurobiol"},{"issue":"2","key":"6171_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pbb.2003.07.002","volume":"76","author":"JE Rose","year":"2003","unstructured":"Rose JE, Behm FM, Westman EC, Bates JE, Salley A (2003) Pharmacologic and sensorimotor components of satiation in cigarette smoking. Pharmacol Biochem Behav 76(2):243\u2013250. https:\/\/doi.org\/10.1016\/j.pbb.2003.07.002","journal-title":"Pharmacol Biochem Behav"},{"key":"6171_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106567","volume":"150","author":"LJ Rosen","year":"2021","unstructured":"Rosen LJ, Galili T, Kott J, Rees V (2021) Beyond \u201csafe and effective\u201d: the urgent need for high-impact smoking cessation medications. Prev Med 150:106567. https:\/\/doi.org\/10.1016\/j.ypmed.2021.106567","journal-title":"Prev Med"},{"key":"6171_CR35","doi-asserted-by":"publisher","unstructured":"Shahab L, Dobbie F, Hiscock R, McNeill A, Bauld L (2016) Prevalence and impact of long-term use of nicotine replacement therapy in UK Stop-Smoking Services: findings from the ELONS Study. Nicotine Tobacco Res ntw58. https:\/\/doi.org\/10.1093\/ntr\/ntw258","DOI":"10.1093\/ntr\/ntw258"},{"issue":"12","key":"6171_CR36","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1360-0443.2003.00575.x","volume":"98","author":"S Shiffman","year":"2003","unstructured":"Shiffman S, Hughes JR, Di Marino ME, Sweeney CT (2003) Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking: misuse of nicotine gum. Addiction 98(12):1747\u20131753. https:\/\/doi.org\/10.1111\/j.1360-0443.2003.00575.x","journal-title":"Addiction"},{"issue":"2","key":"6171_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.amepre.2007.09.033","volume":"34","author":"S Shiffman","year":"2008","unstructured":"Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG (2008) Use of smoking-cessation treatments in the United States. Am J Prev Med 34(2):102\u2013111. https:\/\/doi.org\/10.1016\/j.amepre.2007.09.033","journal-title":"Am J Prev Med"},{"issue":"17","key":"6171_CR38","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s00213-017-4665-y","volume":"234","author":"MF Stiles","year":"2017","unstructured":"Stiles MF, Campbell LR, Graff DW, Jones BA, Fant RV, Henningfield JE (2017) Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability. Psychopharmacology 234(17):2643\u20132655. https:\/\/doi.org\/10.1007\/s00213-017-4665-y","journal-title":"Psychopharmacology"},{"issue":"2","key":"6171_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1037\/0893-164X.21.2.216","volume":"21","author":"BA Toll","year":"2007","unstructured":"Toll BA, O\u2019Malley SS, McKee SA, Salovey P, Krishnan-Sarin S (2007) Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav 21(2):216\u2013225. https:\/\/doi.org\/10.1037\/0893-164X.21.2.216","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"6171_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF02245414","volume":"106","author":"KD Ward","year":"1992","unstructured":"Ward KD, Garvey AJ, Bliss RE (1992) Evidence of transient heart rate change after smoking cessation. Psychopharmacology 106(3):337\u2013340. https:\/\/doi.org\/10.1007\/BF02245414","journal-title":"Psychopharmacology"},{"key":"6171_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s002130000382","volume":"149","author":"R West","year":"2000","unstructured":"West R, Hajek P, Foulds J, Nilsson F, May S, Meadows A (2000) A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 149:198\u2013202","journal-title":"Psychopharmacology"},{"key":"6171_CR42","unstructured":"Westman EC, Levin ED, Rose JE (1992) Smoking while wearing the nicotine patch-is smoking satisfying or harmful. Clin Res 40(4):A871\u2013A871"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06171-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T06:07:45Z","timestamp":1660716465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06171-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["6171"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06171-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JER and FMB disclose research support from Foundation for a Smoke-Free World, Philip Morris International, Altria, Embera Neurotherapeutics, Inc., Otsuka Pharmaceutical, JUUL Labs, consulting with Revive pharmaceuticals, and consulting and patent purchase agreement with Philip Morris International.JM is Nicotine BRST\u2019s Chief Scientific Officer at which he holds an equity interest.FV has consulted with Revive Therapeutics.TLB, DRB, and PNW disclose research support from Foundation for a Smoke-Free World, Philip Morris International, Altria, Embera Neurotherapeutics, Inc., Otsuka Pharmaceutical, and JUUL Labs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}